Congenital heart disease (CHD) is rarely cured in the traditional sense. Surgery and other procedures can repair structural defects, and many people go on to live full, active lives, but the heart is not returned to a completely normal state. About 97% of children born with CHD now survive into adulthood, a dramatic improvement from just a few decades ago. Still, most of these individuals need some level of ongoing cardiac monitoring, and the word doctors use is “repaired” rather than “cured” for good reason.
Why Doctors Say “Repaired,” Not “Cured”
The distinction matters more than it might seem. A successful repair corrects the immediate structural problem, restoring blood flow and oxygen levels to normal or near-normal. But the heart tissue itself was formed differently during development, and surgery doesn’t change that underlying biology. Research published through the NIH has noted that a false impression of success is frequently based on early results after surgery, while long-term data tell a more complicated story. Some patients who appear fully repaired develop serious complications years or even decades later, including high blood pressure in the lungs, heart rhythm problems, heart failure, and blood clots.
This doesn’t mean the repair failed. It means that a repaired congenital heart is not the same as a heart that formed normally in the first place. The repair addressed the defect, but the heart may still behave differently over a lifetime.
Simple Defects Come Closest to a Cure
The defects most likely to produce a near-normal outcome are the simpler ones: holes between the heart’s chambers (known as atrial septal defects and ventricular septal defects) and narrowed vessels that can be widened. When these are caught early and repaired, many people do extremely well for decades.
A long-term study tracking patients with isolated ventricular septal defect repairs into their fifth decade found cumulative survival of 80% and event-free survival of 62%. That 62% figure means roughly six in ten patients went decades without needing another procedure, developing an arrhythmia, or having another significant cardiac event. For patients whose hole in the heart was their only problem, that’s a strong result, though it also shows that nearly four in ten experienced some complication over the long haul.
Survival from simple CHD has also improved enormously over time. A Danish study spanning 39 years found that one-year mortality for people aged 30 to 60 diagnosed with simple CHD dropped from 9.5% in the late 1970s to just 1% by 2007 to 2015. For those over 60, it fell from about 31% to under 10%. Among younger adults aged 5 to 30, mortality effectively reached zero. These numbers reflect both better surgical techniques and better long-term care.
Complex Defects Require Lifelong Management
For more complex conditions, the picture is different. Defects like tetralogy of Fallot (where multiple structural problems occur together) or hypoplastic left heart syndrome (where the left side of the heart is severely underdeveloped) require staged surgeries, sometimes starting in the first days of life. These procedures are increasingly successful at sustaining life, but they do not produce a normal heart.
The 2025 guidelines from the American College of Cardiology and American Heart Association recommend that adults with repaired tetralogy of Fallot receive regular imaging to check for valve dysfunction, changes in heart chamber size, and residual holes. Adults with a bicuspid aortic valve (a valve born with two flaps instead of three) need lifelong monitoring if their aorta has enlarged, because of the risk of a tear in the vessel wall. These aren’t optional follow-ups. They’re built into the standard of care because late complications are expected, not unusual.
Common issues that surface years after repair include abnormal heart rhythms, gradual weakening of the heart muscle, elevated pressure in the lung arteries, and problems with replacement valves or patches wearing out over time.
Catheter-Based Repairs Are Changing the Equation
One major shift in treatment is the growing use of catheter-based procedures, where doctors thread a thin tube through a blood vessel to repair defects without opening the chest. For certain types of atrial septal defects, catheter closure has become the preferred approach over surgery, especially in older adults. Studies show equivalent long-term outcomes with shorter hospital stays, lower complication rates, and no risk of the nerve damage to the heart’s electrical system that occurs in roughly 6% of surgical cases.
Catheter-based pulmonary valve replacement, used when a repaired heart’s pulmonary valve wears out, has shown similar valve performance to surgical replacement during medium-term follow-up, with shorter recovery times and fewer procedure-related complications. For ventricular septal defects, a meta-analysis found a 97.8% success rate for catheter-based closure. These less invasive options don’t change whether CHD is “cured,” but they make repeat interventions far easier to tolerate, which matters enormously when you’re facing a lifetime of cardiac care.
What Daily Life Looks Like After Repair
Most people with repaired simple CHD live without significant restrictions. They work, exercise, and have families. Physical activity recommendations vary depending on the specific defect and how well the repair is holding up. Many people with straightforward repairs can participate in competitive sports. Those with more complex repairs, particularly if heart function is reduced or arrhythmias are present, may need to stick to moderate or low-intensity activities.
People with severe dysfunction of the heart’s pumping chambers or uncontrolled rhythm problems are generally advised to avoid competitive sports, though light leisure activity is still encouraged. The key is that recommendations are individualized. Two people with the same original diagnosis can have very different exercise profiles depending on how their hearts responded to repair.
The Practical Reality of Living With CHD
The honest answer to “is congenital heart disease curable?” is that it’s treatable, often very successfully, but not curable in the way that an infection can be cured with antibiotics. A repaired heart still needs watching. The frequency of follow-up visits depends on the complexity of the original defect: someone with a simple, well-healed septal defect might see a cardiologist every few years, while someone with a complex repair might go annually or more often.
What has changed is the outlook. CHD was once a death sentence for many children. Today, 97% reach adulthood, and the adult CHD population is growing rapidly. Survival for simple defects like ventricular septal defects has climbed from 84% to 98% over the past four decades. The goal of treatment has shifted from merely surviving childhood to living a long, full life with a heart that works differently but works well enough. For many people, that functional result is close enough to a cure that the distinction becomes largely academic. For others, particularly those with complex defects, the ongoing nature of their care is a defining part of life, one that modern medicine makes increasingly manageable.